Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries India Globalization Capital Inc (NY: IGC ) 0.3690 -0.0063 (-1.68%) Official Closing Price Updated: 8:00 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about India Globalization Capital Inc < Previous 1 2 3 Next > IGC Stock Earnings: IGC Pharma Beats EPS, Misses Revenue for Q1 2025 August 12, 2024 IGC stock results show that IGC Pharma beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2025. Via InvestorPlace IGC Pharma Revenue Declines 51% YoY Due To Completion Of Its Legacy Project In India, Highlights Important Milestones In Alzheimer's Research August 09, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday June 25, 2024 Pre-market stock movers are worth checking out on Tuesday as we get into all of the hottest news worth reading about this morning! Via InvestorPlace IGC Stock Earnings: IGC Pharma Meets EPS, Beats Revenue for Q4 2024 June 24, 2024 IGC stock results show that IGC Pharma met analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2024. Via InvestorPlace Hedge Fund Settles At $2.25M With SEC For Exposed Short Seller Deal, 2 Cannabis Stocks Affected June 13, 2024 Discover how Anson Funds settled with the SEC for $2.25M over an undisclosed collaboration with short seller impacting cannabis stocks Via Benzinga Topics Cannabis Regulatory Compliance Exposures Cannabis Legal Regulatory 12 Health Care Stocks Moving In Tuesday's Pre-Market Session June 11, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session June 04, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session May 31, 2024 Via Benzinga 6.7 Million Americans Live With Alzheimer’s – IGC Pharma Believes They Deserve Treatment Options Without Black Box Warnings May 09, 2024 6.7 Million Americans Live With Alzheimer’s – IGC Pharma Believes They Deserve Treatment Options Without Black Box Warnings Via News Direct 12 Health Care Stocks Moving In Wednesday's Pre-Market Session May 01, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday May 01, 2024 It's time to dive into the biggest pre-market stock movers as we check out all of the hottest news for Wednesday morning! Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday April 29, 2024 Pre-market stock movers are a great way to start the week as we check out all of the biggest news moving shares on Monday! Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's After-Market Session April 16, 2024 Via Benzinga IGC Pharma Says Cannabinoid-Based Drug Candidate Provides Fast Relief With Fewer Side Effects For Alzheimer's-Associated Agitation April 16, 2024 IGC Pharma shares encouraging interim data from Phase 2 trial of IGC-AD1 for Alzheimer's agitation. Results suggest significant reduction in agitation with minimal side effects compared to placebo. Via Benzinga Who's Who In Cannabis: Latest Executive Changes You Should Know About April 15, 2024 Via Benzinga IGC Pharma Releases Positive Interim Analysis Of Its Ongoing Phase 2 Trial In Alzheimer's Research April 03, 2024 --News Direct-- Via News Direct IGC Pharma Releases Positive Interim Analysis Of Its Ongoing Phase 2 Trial In Alzheimer's Research April 02, 2024 Via Benzinga EXCLUSIVE: Revolutionary Alzheimer's Drug By IGC Shows Early Success March 20, 2024 IGC Pharma's breakthrough Alzheimer's drug, IGC-AD1, shows promising interim results in reducing cognitive and behavioral symptoms, offering hope for patients and families. Its dual-action capability... Via Benzinga Alzheimer's-Focused Small Cap Firm IGC Pharma Releases Data, Candidate Reduces Agitation Compared To Placebo March 20, 2024 IGC Pharma unveils interim results of Phase 2 trial of IGC-AD1 for Agitation in Alzheimer's Dementia. Shows reduction in agitation vs. placebo observed. Via Benzinga Benzinga's 2024 Virtual Healthcare: What's Next In Health? March 19, 2024 The 2024 Benzinga Virtual Healthcare Summit brings together top healthcare professionals and companies to discuss industry trends, advancements in technology, and the future of healthcare. Don't miss... Via Benzinga IGC Pharma Advances In Alzheimer's Research From Pre-clinical Studies To Phase Two Trial With Its Novel Therapy Candidate IGC-AD1 March 19, 2024 --News Direct-- Via News Direct 12 Health Care Stocks Moving In Wednesday's After-Market Session February 28, 2024 Via Benzinga IGC Pharma Announces Q3 2024 Earnings: Strategic Patent Achievements Propel Forward Amid Losses February 19, 2024 IGC Pharma's Q3 2024 results: Navigating financial dips with strategic patents in pain treatment and Alzheimer's therapy. Via Benzinga Topics Intellectual Property Exposures Intellectual Property Why IGC Pharma Stock Is Moving Higher January 23, 2024 IGC Pharma highlighted data from a trial in which the group treated with TGR-63 showed a 78% and 85% reduction in the cortical and hippocampal amyloid load, respectively, reaffirming its potential to... Via Benzinga AI And THC: IGC Pharma Teams Up With Colombian University For Alzheimer's Treatment Research November 21, 2023 IGC Pharma partners with University of Los Andes, to leverage AI for improving Alzheimer's disease treatment and clinical trial efficiency. Via Benzinga Topics Artificial Intelligence Exposures Artificial Intelligence Cannabis Based Pain Relief Solution Receives European Patent Approval October 20, 2023 IGC Pharma, Inc. (NYSE American: IGC) has been granted European Patent No. 3193862 by the European Patent Office for its innovative "Cannabinoid Composition and Method for Treating Pain." Via Benzinga Topics Cannabis Intellectual Property Exposures Cannabis Intellectual Property 12 Health Care Stocks Moving In Thursday's After-Market Session September 21, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session September 12, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session September 01, 2023 Via Benzinga IGC Pharma FY23 Revenue Grows 129%, What About Net Loss? July 12, 2023 IGC Pharma, Inc. (AMEX:IGC) released its financial results for the fiscal year ended March 31, 2023, revealing revenue of $911,000, an increase of 129% compared to $397,000 in fiscal year 2022. FY 2023... Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.